63 related articles for article (PubMed ID: 12173025)
1. A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency.
Al-Taie OH; Seufert J; Mörk H; Treis H; Mentrup B; Thalheimer A; Starostik P; Abel J; Scheurlen M; Köhrle J; Jakob F
Eur J Hum Genet; 2002 Sep; 10(9):499-504. PubMed ID: 12173025
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis.
Al-Taie OH; Uceyler N; Eubner U; Jakob F; Mörk H; Scheurlen M; Brigelius-Flohe R; Schöttker K; Abel J; Thalheimer A; Katzenberger T; Illert B; Melcher R; Köhrle J
Nutr Cancer; 2004; 48(1):6-14. PubMed ID: 15203372
[TBL] [Abstract][Full Text] [Related]
3. Selenoprotein P: properties, functions, and regulation.
Mostert V
Arch Biochem Biophys; 2000 Apr; 376(2):433-8. PubMed ID: 10775431
[TBL] [Abstract][Full Text] [Related]
4. Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse.
Walker SJ; Grant KA; Vrana KE
Alcohol Clin Exp Res; 2001 Aug; 25(8):1114-8. PubMed ID: 11505041
[TBL] [Abstract][Full Text] [Related]
5. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
6. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
[TBL] [Abstract][Full Text] [Related]
7. Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.
Morán A; Iniesta P; de Juan C; García-Aranda C; Díaz-López A; Benito M
Cancer Res; 2005 May; 65(9):3811-4. PubMed ID: 15867378
[TBL] [Abstract][Full Text] [Related]
8. Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.
Wang W; Jaiswal AK
Free Radic Biol Med; 2004 Oct; 37(8):1231-43. PubMed ID: 15451063
[TBL] [Abstract][Full Text] [Related]
9. Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells.
Pearce EG; Laxton RC; Pereira AC; Ye S
Mol Cancer Res; 2007 Mar; 5(3):221-7. PubMed ID: 17339606
[TBL] [Abstract][Full Text] [Related]
10. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status.
Méplan C; Nicol F; Burtle BT; Crosley LK; Arthur JR; Mathers JC; Hesketh JE
Antioxid Redox Signal; 2009 Nov; 11(11):2631-40. PubMed ID: 19453253
[TBL] [Abstract][Full Text] [Related]
11. Modulation of selenoprotein P expression by TGF-beta(1) is mediated by Smad proteins.
Mostert V; Dreher I; Köhrle J; Wolff S; Abel J
Biofactors; 2001; 14(1-4):135-42. PubMed ID: 11568450
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
[TBL] [Abstract][Full Text] [Related]
13. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
[TBL] [Abstract][Full Text] [Related]
14. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
16. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
17. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
Hsieh YY; Wang JP; Lin CS
Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
[TBL] [Abstract][Full Text] [Related]
18. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.
Hienonen T; Sammalkorpi H; Enholm S; Alhopuro P; Barber TD; Lehtonen R; Nupponen NN; Lehtonen H; Salovaara R; Mecklin JP; Järvinen H; Koistinen R; Arango D; Launonen V; Vogelstein B; Karhu A; Aaltonen LA
Cancer Res; 2005 Jun; 65(11):4607-13. PubMed ID: 15930278
[TBL] [Abstract][Full Text] [Related]
19. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
[TBL] [Abstract][Full Text] [Related]
20. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
